BIFIDO Co., Ltd. (KOSDAQ:238200)
 3,660.00
 -30.00 (-0.81%)
  At close: Oct 24, 2025
BIFIDO Company Description
BIFIDO Co., Ltd. produces probiotics-based products in South Korea and internationally.
It offers bifidobacterium strain products, such as BGN4 for immune modulating; BORI used to treat rotavirus infection in infants; and AD011 for general intestinal health problems.
The company was founded in 1999 and is headquartered in Hongcheon-eup, South Korea.
BIFIDO Co., Ltd.
  | Country | South Korea | 
| Founded | 1999 | 
| Industry | Pharmaceutical Preparations | 
| Employees | 83 | 
Contact Details
| Address: 23-16 Nonggongdanji-gil Hongcheon-eup South Korea | |
| Phone | 82 3 3435 4962 | 
| Website | bifido.com | 
Stock Details
| Ticker Symbol | 238200 | 
| Exchange | KOSDAQ | 
| Stock Type | Common Stock | 
| Fiscal Year | January - December | 
| Reporting Currency | KRW | 
| SIC Code | 2834 |